ORKA Oruka Therapeutics, Inc.

HealthcareBiotechnology
$64.07
▼ 8.20%
36
QScore Signal
Short
Confidence: MEDIUM
Long-Term
27
Short-Term
45

Value

29
P/E-33.07
8
P/B7.39
43
P/S0.00
70
EV/EBITDA-21.37
5

Growth

38
Revenue Growth0.0%
28
EPS Growth53.7%
47
FCF Growth-52.4%
38

Momentum

80
12-Month Return589.7%
100
3-Month Return103.9%
100
1-Month Return3.3%
59
RSI (14)43.75
50
50/200 MABullish
75

Profitability

20
ROE-25.3%
46
ROA-21.6%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-3.7%
0

Risk

9
Beta-0.25
20
60-Day Volatility82.4%
0

Generated 5/7/2026, 9:59:03 PM · How is this calculated?

QScore Analysis